BOSTON, Aug. 22, 2017 /PRNewswire/ -- InfoBionic, a
digital health company focused on creating superior solutions for
outpatient cardiac arrhythmia monitoring, has announced the
appointment of Gene Cattarina to its
Board of Directors. Mr. Cattarina brings over 40 years of
experience in numerous senior executive positions at companies in
healthcare information systems, products, medical devices, and
professional services, and will apply his veteran insights to help
InfoBionic continue to scale up commercialization of its
market-shifting MoMe® Kardia Software as a Service (SaaS) remote
cardiac monitoring platform.
Mr. Cattarina is CEO of SafeOp Surgical, Inc., a medical device
company that has developed the FDA-approved EPAD™ system for
simplified neurological monitoring in a wide array of surgical
procedures where full monitoring may not be indicated,
cost-effective, or feasible. Prior to SafeOp, Mr. Cattarina was
president and CEO of Capsule Technologie, Inc., a leading global
provider of medical device integration solutions that was acquired
by Qualcomm, Inc. (NASDAQ: QCOM) in 2015. He has also held CEO
positions at Impulse Monitoring Systems, Inc., now a part of
NuVasive (NASDAQ: NUVA); LYNX Medical Systems, Inc., now a part of
OptumInsight, Inc.; Landacorp, Inc.; and Medicode, Inc., also now a
part of OptumInsight, Inc.
"For decades, Gene has been on the forefront of healthcare
information technology and medical device innovation, and his track
record of success speaks for itself," said Stuart Long, CEO of InfoBionic. "His experience,
perspective, and counsel will no doubt be of great value to
InfoBionic as we continue to scale our disruptive platform, work to
expand our operations, and realize our vision to redefine the
standard of care in ways that benefit healthcare providers, their
practices, and the patients they serve."
"InfoBionic is challenging the status quo of traditional,
complex processes for remote cardiac monitoring, offering
innovative full disclosure technology in a game-changing business
model," said Mr. Cattarina. "I look forward to working with
InfoBionic's exceptional team, and to contributing to the future
direction and growth of their transformative platform."
About InfoBionic
InfoBionic is a digital health
company focused on creating superior patient monitoring solutions
for chronic disease management with an initial market focus on
cardiac arrhythmias. InfoBionic's lead product, MoMe® Kardia, is
the only remote cardiac arrhythmia detection and monitoring system
that replicates in-hospital telemetry data, right in the office, by
giving physicians 24/7 on-demand access to full disclosure Holter,
Event, and MCT data via a HIPAA-compliant portal app. For more
information, visit www.infobionic.com.
Media Contact:
Carla
Nieser
610.240.0400, ext. 108
c.nieser@voveo.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/infobionic-appoints-gene-cattarina-to-board-of-directors-300507451.html
SOURCE InfoBionic